🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multicenter, observational study aimed at exploring ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06649422
Treatments Being Tested
This is a single-arm, prospective, phase 2 clinical trial evaluating the im...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2025-04-01
Trial ID
NCT07564453
Blinatumomab, a CD3/CD19 bisespecific T-cell conjugative antibody, has show...
Status
Completed
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-09-08
Trial ID
NCT05557110
Treatments Being Tested
The trial proposed here attempts to reduce induction chemotherapy to phase ...
Status
Completed
Location
University Hospital of Frankfurt (Main)
Start Date
2018-06-01
Trial ID
NCT03480438
Treatments Being Tested
The purpose of this study is to test whether blinatumomab in combination wi...
Status
Active Not Recruiting
Location
Mount Sinai Hospital
Start Date
2020-03-30
Trial ID
NCT04329325
Treatments Being Tested
This is an open-label, prospective clinical cohort study evaluating the eff...
Status
Recruiting
Location
Blood Diseases Hospital
Start Date
2026-04-10
Trial ID
NCT07493161
This prospective clinical trial evaluates the effectiveness and safety of "...
Status
Recruiting
Location
Anhui Medical University Second Affiliated Hospita
Start Date
2025-03-28
Trial ID
NCT07152041
Treatments Being Tested
This is a prospective, open-label, single-arm, umbrella phase 2 clinical tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-12
Trial ID
NCT07643103
The current Standard of Care (SoC) in younger patients with Ph+ ALL is Imat...
Status
Recruiting
Location
Uniklinik RWTH Aachen
Start Date
2023-07-14
Trial ID
NCT06061094
Treatments Being Tested
Precursor B cell acute lymphoblastic leukemia (B-ALL) is an aggressive type...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003
Start Date
2024-10-17
Trial ID
NCT06742515
Treatments Being Tested